BDPT · Bioadaptives, Inc. · Executive Compensation
$0.00
0.00 (-5.56%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The ability to successfully resolve these factors raises substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 19, 2026
Market Cap
$334,775
Shares
196.93M
Volume · Oct 19
20.88M
Avg daily vol (3M)
25.47M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Reed Harris | Advisory Board | Appointed | 2025-02-07 |
| Mark Frissora | Board of Directors | Appointed | 2025-02-07 |
| James Keener | CEO | Appointed | 2024-05-22 |
| Robert Ellis | President | Resigned | 2024-05-22 |
| Edward Jacobs | CEO | Resigned | 2024-05-22 |
| James Keener | Chairman of the Board | Appointed | 2024-05-22 |
| Robert Ellis | Board Member | Resigned | 2024-05-22 |
| Edward Jacobs | Chairman of the Board | Resigned | 2024-05-22 |
| Dr. Yaguang Liu | Board of Directors | Appointed | 2023-04-06 |
Leadership
- James Keener CEO, Chairman
- Ronald Lambrecht CFO
- Charles Townsend COO, Board Member
- Dr. Yaguang Liu Board Member
- Mark Frissora Board Member
- Robert W. Ellis Board Member
- Yaguang Liu Board Member
Key facts
CIK
1575142